News

ATE24 Lisbon

ATE24 Lisbon

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to ATE24 Lisbon, Portugal

read more
2400 1800 Anemocyte
Plasmid Manufacturing: From Downstream to Filling

Plasmid Manufacturing: From Downstream to Filling

Downstream process is fine tuned to recover the soluble fraction of plasmidic DNA, whereas the genomic DNA, proteins polysaccharides and total RNA from E. coli cells are precipitated and removed by depth filtration.

read more
1201 900 Anemocyte
The Role of Plasmid DNA in Viral Vector Production for Gene Therapy

The Role of Plasmid DNA in Viral Vector Production for Gene Therapy

The utilization of plasmid DNA in the production of viral vectors for gene therapy represents a critical advancement in medical biotechnology.

read more
1201 900 Anemocyte
Plasmids for Lentivirus and AAV Manufacturing

Plasmids for Lentivirus and AAV Manufacturing

Lentiviruses and adeno-associated viruses (AAV) require specific plasmids for their production, which ensure efficient vector generation and safe delivery of the gene of interest (GOI).

read more
1201 900 Anemocyte
mRNA Manufacturing Process

mRNA Manufacturing Process

Many people first became familiar with the term “mRNA” when COVID-19 vaccines were rolled out. In the simplest terms, mRNA, which stands for messenger ribonucleic acid, is a genetic material that instructs the cells to make specific proteins.

read more
1200 900 Anemocyte
BIO International Convention

BIO International Convention

BIO International Convention 3-6 june 2024 | San Diego. Meet us at Italian Pavilion at booth #3623(Anemocyte table, H).

read more
1536 1152 Anemocyte
ISCT

ISCT

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to ISCT 2024 in Vancouver

read more
2400 1800 Anemocyte
ASGCT

ASGCT

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to ASGCT Annual Meeting 2024 in Baltimore

read more
2400 1800 Anemocyte
CPHI Japan

CPHI Japan

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to CPHI Japan 2024

read more
2400 1800 Anemocyte
Cell & Gene

Cell & Gene

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to Cell & Gene Meeting 2024 in Rome

read more
2400 1800 Anemocyte

Anemocyte S.r.l. Single Shareholder Private Limited-Liability Company
Via R. Lepetit, 34 21040 Gerenzano (VA) Italy | Ph: +39 02 99372311 – Fax: +39 02 99372313 | VAT number: 12914940155 | Share capital € 530.000,00 fully paid | R.E.A. 276961